Doxapram vs no treatment, placebo, methylxanthine (including theophylline, aminophylline, or caffeine), or
Chronic lung disease · treatment of apnea
The review found no eligible studies for this question.
3 findings from 1 review
- Doxapram for the prevention and treatment of apnea in preterm infants 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
- Doxapram for the prevention and treatment of apnea in preterm infants 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
- Doxapram for the prevention and treatment of apnea in preterm infants 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found